Intrinsic Imaging Awarded Interventional Medical Device Trial for Prevention of Pulmonary Emboli

Boston, MA / San Antonio, TX — March 3, 2015 — Intrinsic Imaging, an FDA audited, ISO 9001:2008 and ISO 13485:2003 certified medical imaging core lab specializing in providing imaging core lab services for clinical trials, announced today that it has been awarded an interventional medical device clinical trial designed to evaluate a novel device for the prevention of pulmonary emboli.

Throughout this trial, Intrinsic Imaging will provide comprehensive imaging core lab services including specialized radiologic review and analysis of images by its team of board-certified, fellowship-trained interventional radiologists.

Pulmonary embolism is a serious and potentially life-threatening complication of venous thromboembolism. Inferior vena cava filters and related interventional devices play an important role in the prevention of pulmonary emboli in patients at high risk.